sirt modulates aggregation toxicity deacetylation androgen receptor cell models sbma montie hl pestell rg merry de published journal neurosciece nov source departments biochemistry molecular biology cancer biology thomas jefferson university philadelphia pennsylvania abstract posttranslational protein modifications play major role disease pathogenesis phosphorylation sumoylation acetylation modulate toxicity variety proteotoxic proteins androgen receptor substantially modified response hormone binding phosphorylation sumoylation acetylation modifications might thus contribute dht dependent polyglutamine polyq expanded proteotoxicity spinal bulbar muscular atrophy sbma sirt nuclear protein deacetylase neuroprotective many neurodegenerative disease models studies reveal sirt also offers protection polyq expanded deacetylating lysines finding suggested nuclear acetylation plays role aberrant metabolism toxicity polyq expanded subsequent studies revealed polyq expanded hyperacetylated pharmacologic reduction acetylation reduces mutant aggregation moreover genetic mutation inhibit polyq expanded acetylation lysines substantially decreased aggregation completely abrogated toxicity cell lines motor neurons studies also reveal one means acetylation state likely modifies polyq expanded metabolism toxicity effect dht dependent stabilization overall findings reveal neuroprotective function sirt operates deacetylation polyq expanded highlight potential sirt acetylation powerful therapeutic targets sbma explanation ed meyertholen researchers found means living kennedy disease find paper investigation related effect modifying androgen receptor toxicity mutant cells brief introduction kennedy disease aka kd sbma due mutation gene tells cell make protein called androgen receptor generally believe mutation results formation toxic product cell removing old toxic fragment results death certain nerve cells known motor neurons death cells thought ultimately responsible formation symptoms kennedy disease many studies kennedy disease involve attempts reducing toxicity fragment cells often modify proteins alter activity one alteration addition small molecule called acetyl group protein addition group special name acetylation removing acetyl group deacetylation study primarily found reduce amount acetylation mutant cells die even though mutant form mean kennedy disease patients one difficult aspects kennedy disease scientists know enough normal factors affect working makes difficult determine kills cells study could open new pathway discovering drugs chemicals may reduce kennedy disease symptoms one could find drug stimulates deacetylation could therapeutic